These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 19820106)

  • 1. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.
    ; Zwahlen M; Harris R; May M; Hogg R; Costagliola D; de Wolf F; Gill J; Fätkenheuer G; Lewden C; Saag M; Staszewski S; d'Arminio Monforte A; Casabona J; Lampe F; Justice A; von Wyl V; Egger M
    Int J Epidemiol; 2009 Dec; 38(6):1624-33. PubMed ID: 19820106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.
    Brinkhof MW; Boulle A; Weigel R; Messou E; Mathers C; Orrell C; Dabis F; Pascoe M; Egger M;
    PLoS Med; 2009 Apr; 6(4):e1000066. PubMed ID: 19399157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.
    ; Lodwick RK; Sabin CA; Porter K; Ledergerber B; van Sighem A; Cozzi-Lepri A; Khaykin P; Mocroft A; Jacobson L; De Wit S; Obel N; Castagna A; Wasmuth JC; Gill J; Klein MB; Gange S; Riera M; Mussini C; Gutiérrez F; Touloumi G; Carrieri P; Guest JL; Brockmeyer NH; Phillips AN
    Lancet; 2010 Jul; 376(9738):340-5. PubMed ID: 20638118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study.
    Coelho L; Grinsztejn B; Castilho JL; De Boni R; Quintana MS; Campos DP; Ribeiro SR; Pacheco AG; Veloso VG; Luz PM
    Lancet HIV; 2016 Oct; 3(10):e490-8. PubMed ID: 27658875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE.
    ; Young J; Psichogiou M; Meyer L; Ayayi S; Grabar S; Raffi F; Reiss P; Gazzard B; Sharland M; Gutierrez F; Obel N; Kirk O; Miro JM; Furrer H; Castagna A; De Wit S; Muñoz J; Kjaer J; Grarup J; Chêne G; Bucher H
    PLoS Med; 2012; 9(3):e1001194. PubMed ID: 22448150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients.
    Ingle SM; May MT; Gill MJ; Mugavero MJ; Lewden C; Abgrall S; Fätkenheuer G; Reiss P; Saag MS; Manzardo C; Grabar S; Bruyand M; Moore D; Mocroft A; Sterling TR; D'Arminio Monforte A; Hernando V; Teira R; Guest J; Cavassini M; Crane HM; Sterne JA;
    Clin Infect Dis; 2014 Jul; 59(2):287-97. PubMed ID: 24771333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies.
    May M; Sterne JA; Sabin C; Costagliola D; Justice AC; Thiébaut R; Gill J; Phillips A; Reiss P; Hogg R; Ledergerber B; D'Arminio Monforte A; Schmeisser N; Staszewski S; Egger M;
    AIDS; 2007 May; 21(9):1185-97. PubMed ID: 17502729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies.
    Chêne G; Sterne JA; May M; Costagliola D; Ledergerber B; Phillips AN; Dabis F; Lundgren J; D'Arminio Monforte A; de Wolf F; Hogg R; Reiss P; Justice A; Leport C; Staszewski S; Gill J; Fatkenheuer G; Egger ME;
    Lancet; 2003 Aug; 362(9385):679-86. PubMed ID: 12957089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study.
    May MT; Vehreschild JJ; Trickey A; Obel N; Reiss P; Bonnet F; Mary-Krause M; Samji H; Cavassini M; Gill MJ; Shepherd LC; Crane HM; d'Arminio Monforte A; Burkholder GA; Johnson MM; Sobrino-Vegas P; Domingo P; Zangerle R; Justice AC; Sterling TR; Miró JM; Sterne JAC; ; Boulle A; Stephan C; Miro JM; Cavassini M; Chêne G; Costagliola D; Dabis F; Monforte AD; Del Amo J; Van Sighem A; Fätkenheuer G; Gill J; Guest J; Haerry DH; Hogg R; Justice A; Shepherd L; Obel N; Crane H; Smith C; Reiss P; Saag M; Sterling T; Teira R; Williams M; Zangerle R; Sterne J; May M; Ingle S; Trickey A
    Clin Infect Dis; 2016 Jun; 62(12):1571-1577. PubMed ID: 27025828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.
    ; Lewden C; Bouteloup V; De Wit S; Sabin C; Mocroft A; Wasmuth JC; van Sighem A; Kirk O; Obel N; Panos G; Ghosn J; Dabis F; Mary-Krause M; Leport C; Perez-Hoyos S; Sobrino-Vegas P; Stephan C; Castagna A; Antinori A; d'Arminio Monforte A; Torti C; Mussini C; Isern V; Calmy A; Teira R; Egger M; Grarup J; Chêne G
    Int J Epidemiol; 2012 Apr; 41(2):433-45. PubMed ID: 22493325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.
    Murray M; Hogg RS; Lima VD; May MT; Moore DM; Abgrall S; Bruyand M; D'Arminio Monforte A; Tural C; Gill MJ; Harris RJ; Reiss P; Justice A; Kirk O; Saag M; Smith CJ; Weber R; Rockstroh J; Khaykin P; Sterne JA;
    HIV Med; 2012 Feb; 13(2):89-97. PubMed ID: 21819529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
    Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
    Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.
    Ledergerber B; Lundgren JD; Walker AS; Sabin C; Justice A; Reiss P; Mussini C; Wit F; d'Arminio Monforte A; Weber R; Fusco G; Staszewski S; Law M; Hogg R; Lampe F; Gill MJ; Castelli F; Phillips AN;
    Lancet; 2004 Jul 3-9; 364(9428):51-62. PubMed ID: 15234856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.
    ; Judd A; Chappell E; Turkova A; Le Coeur S; Noguera-Julian A; Goetghebuer T; Doerholt K; Galli L; Pajkrt D; Marques L; Collins IJ; Gibb DM; González Tome MI; Navarro M; Warszawski J; Königs C; Spoulou V; Prata F; Chiappini E; Naver L; Giaquinto C; Thorne C; Marczynska M; Okhonskaia L; Posfay-Barbe K; Ounchanum P; Techakunakorn P; Kiseleva G; Malyuta R; Volokha A; Ene L; Goodall R
    PLoS Med; 2018 Jan; 15(1):e1002491. PubMed ID: 29381702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population.
    Rodger AJ; Lodwick R; Schechter M; Deeks S; Amin J; Gilson R; Paredes R; Bakowska E; Engsig FN; Phillips A;
    AIDS; 2013 Mar; 27(6):973-979. PubMed ID: 23698063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer.
    Simmons RD; Ciancio BC; Kall MM; Rice BD; Delpech VC
    HIV Med; 2013 Nov; 14(10):596-604. PubMed ID: 23672663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
    Trickey A; May MT; Schommers P; Tate J; Ingle SM; Guest JL; Gill MJ; Zangerle R; Saag M; Reiss P; Monforte AD; Johnson M; Lima VD; Sterling TR; Cavassini M; Wittkop L; Costagliola D; Sterne JAC;
    Clin Infect Dis; 2017 Sep; 65(6):959-966. PubMed ID: 28903507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
    Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
    PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.
    May MT; Hogg RS; Justice AC; Shepherd BE; Costagliola D; Ledergerber B; Thiébaut R; Gill MJ; Kirk O; van Sighem A; Saag MS; Navarro G; Sobrino-Vegas P; Lampe F; Ingle S; Guest JL; Crane HM; D'Arminio Monforte A; Vehreschild JJ; Sterne JA;
    Int J Epidemiol; 2012 Dec; 41(6):1807-20. PubMed ID: 23148105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.